366 related articles for article (PubMed ID: 7650058)
1. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor.
Miao HQ; Fritz TA; Esko JD; Zimmermann J; Yayon A; Vlodavsky I
J Cell Biochem; 1995 Feb; 57(2):173-84. PubMed ID: 7759555
[TBL] [Abstract][Full Text] [Related]
3. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions.
Klagsbrun M
Semin Cancer Biol; 1992 Apr; 3(2):81-7. PubMed ID: 1378313
[TBL] [Abstract][Full Text] [Related]
4. Culture-induced increase in acidic and basic fibroblast growth factor activities and their association with the nuclei of vascular endothelial and smooth muscle cells.
Speir E; Sasse J; Shrivastav S; Casscells W
J Cell Physiol; 1991 May; 147(2):362-73. PubMed ID: 1710230
[TBL] [Abstract][Full Text] [Related]
5. Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular-matrix bound basic fibroblast growth factor.
Thompson K; Rabinovitch M
J Cell Physiol; 1996 Mar; 166(3):495-505. PubMed ID: 8600153
[TBL] [Abstract][Full Text] [Related]
6. Thrombin- and factor Xa-induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells.
Rauch BH; Millette E; Kenagy RD; Daum G; Clowes AW
Circ Res; 2004 Feb; 94(3):340-5. PubMed ID: 14670838
[TBL] [Abstract][Full Text] [Related]
7. Endothelial proteoglycans inhibit bFGF binding and mitogenesis.
Forsten KE; Courant NA; Nugent MA
J Cell Physiol; 1997 Aug; 172(2):209-20. PubMed ID: 9258342
[TBL] [Abstract][Full Text] [Related]
8. Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors.
Rusnati M; Urbinati C; Presta M
J Cell Physiol; 1993 Jan; 154(1):152-61. PubMed ID: 8419401
[TBL] [Abstract][Full Text] [Related]
9. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization.
Logeart D; Prigent-Richard S; Jozefonvicz J; Letourneur D
Eur J Cell Biol; 1997 Dec; 74(4):376-84. PubMed ID: 9438134
[TBL] [Abstract][Full Text] [Related]
10. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic effects of basic FGF and heparin binding EGF conjugated with cytotoxin saporin on vascular cell cultures.
Chen C; Li J; Micko CJ; Pierce GF; Cunningham MR; Lumsden AB
J Surg Res; 1998 Feb; 75(1):35-41. PubMed ID: 9614854
[TBL] [Abstract][Full Text] [Related]
12. Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form.
Presta M; Maier JA; Rusnati M; Ragnotti G
J Cell Physiol; 1989 Jul; 140(1):68-74. PubMed ID: 2500452
[TBL] [Abstract][Full Text] [Related]
13. Release of cell surface-associated basic fibroblast growth factor by glycosylphosphatidylinositol-specific phospholipase C.
Bashkin P; Neufeld G; Gitay-Goren H; Vlodavsky I
J Cell Physiol; 1992 Apr; 151(1):126-37. PubMed ID: 1313817
[TBL] [Abstract][Full Text] [Related]
14. Role of heparan sulfate in the terminal differentiation of growth plate chondrocytes.
Chintala SK; Miller RR; McDevitt CA
Arch Biochem Biophys; 1995 Jan; 316(1):227-34. PubMed ID: 7840621
[TBL] [Abstract][Full Text] [Related]
15. Basic fibroblast growth factor binds to heparan sulfate in the extracellular matrix of rat growth plate chondrocytes.
Chintala SK; Miller RR; McDevitt CA
Arch Biochem Biophys; 1994 Apr; 310(1):180-6. PubMed ID: 8161203
[TBL] [Abstract][Full Text] [Related]
16. Sulfated malto-oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation.
Foxall C; Wei Z; Schaefer ME; Casabonne M; Fugedi P; Peto C; Castellot JJ; Brandley BK
J Cell Physiol; 1996 Sep; 168(3):657-67. PubMed ID: 8816920
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins.
Kazi M; Lundmark K; Religa P; Gouda I; Larm O; Ray A; Swedenborg J; Hedin U
J Cell Physiol; 2002 Dec; 193(3):365-72. PubMed ID: 12384988
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of heparin-mimicking compounds in induction of bFGF release from extracellular matrix and inhibition of smooth muscle cell proliferation and heparanase activity.
Benezra M; Ishai-Michaeli R; Ben-Sasson SA; Vlodavsky I
J Cell Physiol; 2002 Sep; 192(3):276-85. PubMed ID: 12124773
[TBL] [Abstract][Full Text] [Related]
19. Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells.
Sperinde GV; Nugent MA
Biochemistry; 1998 Sep; 37(38):13153-64. PubMed ID: 9748322
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of a bacteria-derived sulfated polysaccharide against basic fibroblast growth factor-induced endothelial cell growth and chemotaxis.
Nakayama Y; Iwahana M; Sakamoto N; Tanaka NG; Osada Y
J Cell Physiol; 1993 Jan; 154(1):1-6. PubMed ID: 8419396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
